A detailed history of Community Bank, N.A. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Community Bank, N.A. holds 970 shares of VRTX stock, worth $455,162. This represents 0.06% of its overall portfolio holdings.

Number of Shares
970
Previous 975 0.51%
Holding current value
$455,162
Previous $457,000 1.31%
% of portfolio
0.06%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$460.0 - $505.78 $2,300 - $2,528
-5 Reduced 0.51%
970 $451,000
Q2 2024

Aug 14, 2024

BUY
$392.81 - $485.53 $382,989 - $473,391
975 New
975 $457,000
Q3 2022

Oct 28, 2022

BUY
$273.83 - $305.53 $4,928 - $5,499
18 New
18 $5,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $120B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Community Bank, N.A. Portfolio

Follow Community Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Community Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Community Bank, N.A. with notifications on news.